MULTI SOLUTIONS II, INC

2024 Q3 Form 10-Q Financial Statement

#000072373324000008 Filed on September 13, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2023 Q3

Balance Sheet

Concept 2024 Q3 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.350K
YoY Change
Cash & Equivalents $2.348K $10.80K
Short-Term Investments
Other Short-Term Assets $4.450K
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $6.800K
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $2.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $6.800K
Total Long-Term Assets $2.00
Total Assets $6.802K
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.300K
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $6.300K
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $1.214M
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $1.214M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $6.300K
Total Long-Term Liabilities $1.214M
Total Liabilities $1.221M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$9.634M
YoY Change
Common Stock $1.900K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.214M -$1.091M
YoY Change
Total Liabilities & Shareholders Equity $6.802K
YoY Change

Cashflow Statement

Concept 2024 Q3 2023 Q3

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Type
DocumentType
10-Q
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-31
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Entity Registrant Name
EntityRegistrantName
MULTI SOLUTIONS II, INC
dei City Area Code
CityAreaCode
305
dei Local Phone Number
LocalPhoneNumber
579-8000
dei Security12b Title
Security12bTitle
Common Stock, par value $.001 per share
dei Trading Symbol
TradingSymbol
MUSS
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
1323 usd
CY2024Q3 us-gaap Assets
Assets
6802 usd
CY2024Q1 us-gaap Assets
Assets
3704 usd
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
6300 usd
CY2024Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
19105 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
6300 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
19105 usd
CY2024Q1 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
1138201 usd
CY2024Q3 us-gaap Liabilities
Liabilities
1220560 usd
CY2024Q1 us-gaap Liabilities
Liabilities
1157306 usd
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
1900 usd
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
1900 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
8418684 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
8418684 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9634342 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9574186 usd
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1213758 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1153602 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6802 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3704 usd
CY2024Q3 us-gaap Revenues
Revenues
0 usd
CY2023Q3 us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
14664 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
13276 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
23597 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
21525 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
14664 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
13276 usd
us-gaap Operating Expenses
OperatingExpenses
23597 usd
us-gaap Operating Expenses
OperatingExpenses
21525 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-14664 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-13276 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-21525 usd
CY2023Q3 us-gaap Interest And Debt Expense
InterestAndDebtExpense
17470 usd
us-gaap Interest And Debt Expense
InterestAndDebtExpense
36559 usd
us-gaap Interest And Debt Expense
InterestAndDebtExpense
33934 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-33459 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-30746 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-60156 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-55459 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1899575 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1899575 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1899575 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1899575 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1899575 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1899575 shares
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
36558 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
33933 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
3131 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
3969 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-12805 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-7886 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-39534 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-33381 usd
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
39501 usd
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
31000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
39501 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
31000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-33 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2381 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2381 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13182 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2348 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10801 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Use Of Estimates
UseOfEstimates
Use of Estimates<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In preparing financial statements in conformity with generally accepted accounting principles, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and expenses during the reported period.  Actual results could differ from those estimates.</span></div>
dei Entity Central Index Key
EntityCentralIndexKey
0000723733
dei Amendment Flag
AmendmentFlag
false
dei Document Period End Date
DocumentPeriodEndDate
2024-07-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
FL
dei Entity File Number
EntityFileNumber
000-12162
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
22-2418056
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33137
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Shell Company
EntityShellCompany
true
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1899575 shares
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2348 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2381 usd
CY2024Q3 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
4454 usd
CY2024Q3 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
1214260 usd
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1899575 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1899575 shares
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-33459 usd
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Address Address Line1
EntityAddressAddressLine1
4400 Biscayne Boulevard, 10th Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
Miami
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1899575 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1899575 shares
us-gaap Operating Income Loss
OperatingIncomeLoss
-23597 usd
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
18795 usd
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
17470 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
36559 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
33934 usd
CY2024Q3 us-gaap Interest And Debt Expense
InterestAndDebtExpense
18795 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-30746 usd
us-gaap Net Income Loss
NetIncomeLoss
-60156 usd
us-gaap Net Income Loss
NetIncomeLoss
-55459 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1899575 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1899575 shares
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-1180299 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-33459 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-1213758 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-1059842 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-30746 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-1090588 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-1153602 usd
us-gaap Net Income Loss
NetIncomeLoss
-60156 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-1213758 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-1035129 usd
us-gaap Net Income Loss
NetIncomeLoss
-55459 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-1090588 usd
us-gaap Net Income Loss
NetIncomeLoss
-60156 usd
us-gaap Net Income Loss
NetIncomeLoss
-55459 usd

Files In Submission

Name View Source Status
0000723733-24-000008-index-headers.html Edgar Link pending
0000723733-24-000008-index.html Edgar Link pending
0000723733-24-000008.txt Edgar Link pending
0000723733-24-000008-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
multi-20240731.htm Edgar Link pending
multi-20240731.xsd Edgar Link pending
q22024ex311.htm Edgar Link pending
q22024ex312.htm Edgar Link pending
q22024ex321.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
multi-20240731_cal.xml Edgar Link unprocessable
multi-20240731_def.xml Edgar Link unprocessable
multi-20240731_lab.xml Edgar Link unprocessable
multi-20240731_pre.xml Edgar Link unprocessable
multi-20240731_htm.xml Edgar Link completed